To investigate the role of the mucus-bicarbonatebarrier in the prevention of duodenal ulcer recurrence, duodenal mucosal neutralizing capacity and mucosal prostaglandin (PG) synthesis were examined in 5 normal controls (NC) and 12 duodenal ulcer (DU) patients. DUpatients were divided into non-recurrent (NR,7) and recurrent (R,5) groups based on endoscopic follow-up study. The recovery time (RT) was significantly longer and the mucosal PGE2 synthesis was significantly lower in R than in NC and NR groups. There was a proportional correlation between mucosal PG synthesis and RT in DUpatients. These results indicate that impaired neutralizing capacity caused by reduced endogenous PG synthesis in duodenal mucosa may contribute to recurrence of DU.
Impaired Neutralizing Capacity of Duodenal Mucosa Following Luminal Acidification in Recurrent
Duodenal Ulcer
Hikaru YOKOTA,Akinori YANAKAand Hiroshi MUTO
To investigate the role of the mucus-bicarbonatebarrier in the prevention of duodenal ulcer recurrence, duodenal mucosal neutralizing capacity and mucosal prostaglandin (PG) synthesis were examined in 5 normal controls (NC) and 12 duodenal ulcer (DU) patients. DUpatients were divided into non-recurrent (NR,7) and recurrent (R,5) groups based on endoscopic follow-up study. The recovery time (RT) was significantly longer and the mucosal PGE2 synthesis was significantly lower in R than in NC and NR groups. There was a proportional correlation between mucosal PG synthesis and RT in DUpatients. These results indicate that impaired neutralizing capacity caused by reduced endogenous PG synthesis in duodenal mucosa may contribute to recurrence of DU. 
PATIENTS AND METHODS

Patients and controls
The present study was carried out on 5 NCand 12 DUpatients who were endoscopically diagnosed to have active duodenal ulcers in the duodenal bulb at the University Hospital of Tsukuba. None of the patients received strong antisecretory drugs such as anticholinergics, histamine H2 receptor antagonists for at least 1 yr before starting the present study. After the active ulcer wasfound, all patients were treated with antacid (3 g/day) during the follow-up period unless they had severe symptoms. Cimetidine (400 mg/day) was temporarily used only for relief from the symptoms. Noneof the patients had complicating diseases, and none took other drugs during the follow-up period. Ulcer healing was confirmed by endoscopy based on the disappearance of the white coat on the ulcer. After confirming that each case of DUhad healed, duodenal mucosal neutralizing capacity and mucosal PG synthesis were examined. In order to monitor recurrence, patients were followed for 1 yr by periodical endoscopic examination performed at three-month intervals.
DUpatients were divided into NRand R groups based on endoscopic follow-up study.
NR group included 7 patients (mean age 44.3 yr, 1 ). Before introduction of the endoscope, the throat was sprayed with 1% lidocaine and sedation was induced with intramuscular diazepam. After the endoscope was inserted into the duodenal bulb, the electrode was passed through the biopsy channel and the electrode tip was gently advanced under direct vision until it touched the mucosawhere the juxtamucosal pH reading was obtained. The tip was placed at the visually normal mucosa of the duodenal cap. After obtaining stable pH values, 10 ml of 0.1 N HC1was infused through the tube for 1 min, and the changes in the juxtamucosal pH of the duodenal cap were continuously recorded.
The basal juxtamucosal pH (basal pH) and the recovery time needed for the juxtamucosal pH to return to its pre-infusion value (RT), which were considered to be an index of mucosal neutralizing capacity, were measured. To evaluate the reflux of 3 from an R group patient (patient 2). After infusion of acid, the value of juxtamucosal pH fell and gradually returned to the previous value. A remarkable difference in RT (å ---i ) was Regarding the basal pH, no difference was found between patient 1 and patient 2. RTwas significantly longer in the R group (6.5 ±0.3 min) than in the NC (1.4±0.3) and NR groups (2.5 ±0.4) (Fig. 4) . There was no difference in basal pHbetween the NC (7.2±0.3), NR(7.8±0.3), and Rgroups (7.5 ±0.1) (Fig. 5) . In all subjects, amylase was not detected in the residual fluid.
Mucosal PGE2 synthesis Figure 6 shows that the duodenal mucosal PGE2 synthesis was significantly lower in the R group (19±3 pg/mg prot/h) than in the NC (36±4) and NR(34 ± 3) groups and that there was no difference in duodenal mucosal PGE2 synthesis between the NC and DU (NR±R) groups (28±4).
Correlation between mucosal PGE2synthesis and RT There was a linear correlation between mucosal PGE2 synthesis and RT in the DU group (Fig. 7) .
DISCUSSION
It has been reported that a pH gradient exists across the duodenal mucus layer, with the pH at the epithelial surface maintained at near neutrality while luminal pH is acidic (4). Furthermore, Quigley and Turnberg measured the juxtamiicosal pH and detected a pH gradient in the humanduodenal cap using microelectrodes endoscopically (5). Their results indicated that the mucus-bicarbonate barrier inhibits mucosal acidification in humansand that the duodenal mucosa in DUpatients is less capable of maintaining an adjacent neutral zone in the face of luminal acid. In the present study, the change in juxtamucosal pH following luminal acidification was measured endoscopically and the RTwas calculated.
Regarding the definition of an index of the mucusbicarbonate barrier, it has been reported that in the duodenumof dogs and humanswhenthe luminal pH is as low as 2.0 the juxtamucosal pH is neutral and that the juxtamucosal pH begins to fall in the face of a luminal pH of <1.5 (6). In this study, with a luminal pH as low as 1.0 for 1 min, the juxtamucosal pHfell momentarily and the time required for the juxtamucosal pHvalue to return to its pre- reported that increased parietal cell responsiveness contributes to the recurrence of DU(13). Weproposed that abnormalities in both mucosal defense and luminal attack may together contribute to the recurrence of DU.
It should be emphasized, however, that the number of patients and control subjects in this study was small. Thus the present results must be confirmed using a variety of technical approaches and broader groups of individuals.
